OSTEOPORE LIMITED — AGM Information 2020

May 18, 2020

==> picture [130 x 44] intentionally omitted <==

ASX RELEASE│OSTEOPORE LIMITED

TELECONFERENCE DETAILS FOR ANNUAL GENERAL MEETING

19 MAY 2020: Osteopore Limited (ASX: OSX) (“Osteopore” or “the Company”) , advises that further to the Company’s announcement on 6 May 2020, the Annual General Meeting to be held at Ground Floor, 16 Ord Street, West Perth, WA 6005 on Friday, 5 June 2020 at 1.00pm (WST) (“AGM” or “Meeting”), will be available to all Shareholders via teleconference which will allow Shareholders to listen and observe the Meeting.

To access the teleconference details, please register yourself by following the instructions at https://s1.c-conf.com/diamondpass/10007028-invite.html. The Company encourages Shareholders to pre-register using the link provided.

IN LIGHT OF THE GLOBAL OUTBREAK OF THE CORONAVIRUS (COVID-19) AND IN THE INTERESTS OF PUBLIC HEALTH AND SAFETY OF OUR SHAREHOLDERS, THE COMPANY IS STRONGLY DISCOURAGING SHAREHOLDERS FROM PHYSICALLY ATTENDING THE AGM AND ENCOURAGING SHAREHOLDERS TO LODGE PROXIES WHICH MUST BE RECEIVED BY 1.00PM (WST) ON WEDNESDAY, 3 JUNE 2020.

How Shareholders Can Participate:

1. Shareholders are strongly urged to appoint the Chair of the Meeting as their proxy . Shareholders can complete the proxy form to provide specific instructions on how a Shareholder’s vote is to be exercised on each item of business, and the Chair of the Meeting must follow your instructions. Lodgement instructions are set out in the Proxy Form attached to the Notice of Annual General Meeting.

2. Shareholders may submit questions in advance of the Meeting to the Company. Should you have any questions, please send these in advance of the Meeting addressed to the Company Secretary via email at info@ventnor.com.au by 5.00pm (WST) on 29 May 2020. Responses will be lodged on the Company's website prior to the commencement of the AGM for all valid questions received prior to 5.00pm (WST) on 29 May 2020.

3. The situation regarding COVID-19 is evolving rapidly and the Company is following the guidance of the Australian Government. Shareholders are encouraged to monitor the Company’s ASX announcements for any further updates in relation to the AGM.

This announcement has been approved for release by the Board of Osteopore.

For more information please contact:

Deborah Ho

Company Secretary Osteopore Limited +618 9482 0500

Osteopore Limited (ACN 630 538 957)│ASX:OSX│16 Ord Street, West Perth│+618 9482 0500│www.osteopore.com